Methods for glucagon suppression
US6872700B1 · kind B1 · utility
117Cited by
7References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2000 |
| Grant date | Mar 29, 2005 |
| Priority date | — |
| Expiry date | Jan 14, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for use of an exendin, an exendin agonist, or a modified exendin or exendin agonist having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, for lowering glucagon levels and/or suppressing glucagon secretion in a subject are provide. These methods are useful in treating hyperglucagonemia and other conditions that would be benefited by lowering plasma glucagon or suppressing glucagon secretion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.